Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis
- 1 October 1997
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 159 (1) , 177-193
- https://doi.org/10.1111/j.1600-065x.1997.tb01015.x
Abstract
The spectrum of disease is influenced by factors related to both the pathogen and the host, as well as the end points used in defining disease. In this article, the issue of disease resistance versus susceptibility will be examined in the framework that genetic manipulation of either the pathogen or the host immune response alters the balance from disease protection towards pathogenesis. The response of the host may trigger both a protective and a pathogenic immune response. The failure CO mount protective immune response predisposes the pathogen to persistence, which then becomes the target for immunopathology. This review will examine the factors involved both in virus‐mediated pathogenesis and in disease protection in the Theiler's model d human multiple scler manipulating the character of the virus pathogen and the specificity of the immune response, the entire spectrum of human demyelinating disease is reproduced.Keywords
This publication has 80 references indexed in Scilit:
- In search of the ‘missing self’: MHC molecules and NK cell recognitionPublished by Elsevier ,2003
- Differential generation of class I H-2D- versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infectionEuropean Journal of Immunology, 1997
- Influence of Deletion of T Cell Receptor VβGenes on the Theiler's Virus Model of Multiple SclerosisAutoimmunity, 1994
- Coexpression of Class I Major Histocompatibility Antigen and Viral RNA in Central Nervous System of Mice Infected With Theiler's Virus: A Model for Multiple SclerosisMayo Clinic Proceedings, 1992
- The Cell Biology Of Antigen Processing And PresentationAnnual Review of Immunology, 1991
- Inhibition of Theiler's Virus-induced demylination in vivo by tumor necrosis factor alphaInternational Immunology, 1990
- Constitutive expression of (2′–5′) oligo A synthetase confers resistance to picornavirus infectionNature, 1987
- Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region.The Journal of Experimental Medicine, 1986
- Virus-Induced Demyelination in Mice: “Dying Back” of OligodendrocytesMayo Clinic Proceedings, 1985
- Theiler's Virus-Induced Demyelination: Prevention by ImmunosuppressionScience, 1976